A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(49 sites)

United States

GSK Investigational Site, Arcadia, California

GSK Investigational Site, Covina, California

GSK Investigational Site, Los Angeles, California

GSK Investigational Site, Santa Maria, California

GSK Investigational Site, Van Nuys, California